483
Bi-Coastal Pharma InternationalFDA 483 - Bi-Coastal Pharma International - September 14, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Bi-Coastal Pharma International, an own label distributor/marketer in Shrewsbury, NJ, was inspected by the FDA from September 8-14, 2020. The inspection revealed a significant deficiency related to the lack of written procedures for handling post-marketing adverse drug experiences. This indicates a serious gap in their pharmacovigilance system.
- Person
Open in Dashboard
ID · 14aa73d5-06a1-4bb1-b620-6b1305d741d4